Skip to main content

Food and Drug Administration


What is the Food and Drug Administration’s position on CBD?

According to an internal government letter released earlier this year, the FDA suggested that CBD does not meet the criteria for federal control.

The FDA weighs eight factors when deciding on scheduling recommendations. After considering those eight factors as they relate to CBD, the agency concluded that “CBD does not meet the criteria for placement in any of Schedules II, III, IV, or V under the CSA.”

Subscribe to Food and Drug Administration